Ewa G Soderstrom

Title: Innovator of Anticoagulation: Ewa G. Soderstrom

Introduction: Ewa G. Soderstrom, an accomplished inventor based in Saltsjöbaden, Sweden, has made significant contributions to the field of pharmaceuticals. With her innovative approach, Soderstrom has secured a patent that showcases the functionality and importance of heparin fragments.

Latest Patents: Soderstrom's sole patent focuses on "Heparin fragments having selective anticoagulation activity." This invention involves heparin fragments consisting of 14-18 sugar units. The primary component is a disaccharide unit known as L-iduronosyl-2-O-sulphate-N-sulpho-U-glucosamine-6-O-sulphate. Notably, unsulphated L-iduronic acid is located 3-5 sugar units from the unreducing terminal. Additionally, the patent covers pharmaceutical compositions that contain such heparin fragments and processes for their preparation.

Career Highlights: Throughout her career, Ewa G. Soderstrom has established herself as a competent inventor within the pharmaceutical industry. Her work at Kabi AB reflects a dedication to advancing medical science through innovative solutions, particularly in anticoagulation therapy.

Collaborations: Soderstrom has collaborated with prominent professionals in her field, including Ulf P. Lindahl and Gudrun E. Backstrom. These partnerships have played a vital role in furthering her research and enhancing the commercial viability of her inventions.

Conclusion: Ewa G. Soderstrom is a notable figure in the realm of pharmaceutical inventions. Her patent on heparin fragments with selective anticoagulation activity represents a significant advancement in therapeutic options. As Soderstrom continues her work at Kabi AB, the implications of her innovations may lead to enhanced patient care and outcomes in anticoagulation treatments.